SHP503-803: Drug Utilization Study with Intuniv® in Australia

First published 28/04/2021

Last updated 14/03/2024

EU PAS number:

EUPAS40684

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

SHP503-803- protocol-original-redact

English (758.68 KB - PDF)View document

Study results

Study results

SHP503-803-clinical-study-report-redact

English (732.02 KB - PDF)View document

Study report

Other information